Close | |
Figure 2: Two months after the injection, fundus examination revealed resolving retinal hemorrhages (a), a dry-appearing macula and a broken OzurdexTM implant in the vitreous cavity (b). A significant decrease in the macular edema with a normal foveal dip was seen on optical coherence tomography. The central macular thickness measured 184 microns. No cystic spaces or subretinal fluid was seen (c) |
|